The introduction of anti-VEGF agents has revolutionized the field of medical retina care by reducing rates of vision loss and ...
21h
Zacks.com on MSNExelixis Gains 6.7% Post Q4 Earnings: Is This the Right Time to Buy?Exelixis, Inc. EXEL reported better-than-expected fourth-quarter results. EXEL recorded earnings of 55 cents per share, which ...
Greatwall, a conserved MAST-like kinase with crucial mitotic entry functions, is curiously absent in worms. Here, the single ...
Patients treated with tyrosine kinase inhibitors received olanzapine to address adverse effects including nausea/vomiting, ...
Investigators from Shanghai, China, report responses above 90% by using levantinib and tislelizumab to treat patients with a ...
A team of researchers have made a new discovery in the field of hematology, providing an explanation for spontaneous and unusual blood-clotting that continues to occur despite treatment with full-dose ...
Researchers at McMaster University have made a groundbreaking discovery in the field of hematology, providing an explanation for spontaneous and unusual blood-clotting that continues to occur despite ...
A team of researchers have made a new discovery in the field of hematology, providing an explanation for spontaneous and ...
Researchers at McMaster University have made a discovery in the field of hematology, providing an explanation for spontaneous and unusual blood-clotting that continues to occur despite treatment with ...
PROVIDENCE, RI - Ocean Biomedical (NASDAQ: OCEA) has announced research findings that show its immunotherapy candidates can work synergistically with tyrosine kinase inhibitors (TKIs), potentially ...
Company Poised to Enter Booming Bispecific Antibody Market Amid Growing Pharma Interest Providence, RI, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Ocean Biomedical (NASDAQ: OCEA) today announced newly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results